Immune Correlates of Protection from Filovirus Efficacy Studies in Non-Human Primates

Non-human primate (NHP) efficacy data for several Ebola virus (EBOV) vaccine candidates exist, but definitive correlates of protection (CoP) have not been demonstrated, although antibodies to the filovirus glycoprotein (GP) antigen and other immunological endpoints have been proposed as potential Co...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Vaccines
المؤلفون الرئيسيون:	Cheryl A. Triplett, Nancy A. Niemuth, Christopher Cirimotich, Gabriel Meister, Mimi Guebre-Xabier, Nita Patel, Mike Massare, Greg Glenn, Gale Smith, Kendra J. Alfson, Yenny Goez-Gazi, Ricardo Carrion
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2022-08-01
الموضوعات:	correlates of protection PsVNA ELISA Marburg virus Sudan virus Ebola virus
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-393X/10/8/1338

مواد مشابهة

Non-Ebola Filoviruses: Potential Threats to Global Health Security
حسب: Yannick Munyeku-Bazitama, وآخرون
منشور في: (2024-07-01)

Adapting Simon’s Two-Stage Design for Efficient Screening of Filovirus Vaccines in Non-Human Primates
حسب: Nancy A. Niemuth, وآخرون
منشور في: (2022-07-01)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
حسب: Axel T. Lehrer, وآخرون
منشور في: (2021-08-01)

Bridging Animal and Human Data in Pursuit of Vaccine Licensure
حسب: Courtney L. Finch, وآخرون
منشور في: (2022-08-01)

Standardization of the Filovirus Plaque Assay for Use in Preclinical Studies
حسب: Gene G. Olinger, وآخرون
منشور في: (2012-12-01)

Comparison of the biological properties of bat-derived filovirus envelope glycoproteins
حسب: Francois Edidi-Atani, وآخرون
منشور في: (2025-10-01)

Obtaining and Immunologic Characterization of Filoviruses Recombinant Proteins VP40 and NP
حسب: A. V. Ivanova, وآخرون
منشور في: (2010-08-01)

Serological Evidence of Filovirus Infection in Nonhuman Primates in Zambia
حسب: Katendi Changula, وآخرون
منشور في: (2021-06-01)

Assays for the Evaluation of the Immune Response to Marburg and Ebola Sudan Vaccination—Filovirus Animal Nonclinical Group Anti-Marburg Virus Glycoprotein Immunoglobulin G Enzyme-Linked Immunosorbent Assay and a Pseudovirion Neutralization Assay
حسب: Thomas L. Rudge, وآخرون
منشور في: (2022-07-01)

Approaches to demonstrating the effectiveness of filovirus vaccines: Lessons from Ebola and COVID-19
حسب: Marion F. Gruber, وآخرون
منشور في: (2023-02-01)

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels
حسب: Machteld M. Tiemessen, وآخرون
منشور في: (2022-08-01)

Selection of Filovirus Isolates for Vaccine Development Programs
حسب: Daniel N. Wolfe, وآخرون
منشور في: (2021-09-01)

A Diacylglycerol Kinase Inhibitor, R-59-022, Blocks Filovirus Internalization in Host Cells
حسب: Corina M. Stewart, وآخرون
منشور في: (2019-03-01)

Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names
حسب: Jens H. Kuhn, وآخرون
منشور في: (2014-09-01)

Development of a Well-Characterized Cynomolgus Macaque Model of Marburg Virus Disease for Support of Vaccine and Therapy Development
حسب: Kendra J. Alfson, وآخرون
منشور في: (2022-08-01)

Modeling Case Burden and Duration of Sudan Ebola Virus Disease Outbreak in Uganda, 2022
حسب: Donal Bisanzio, وآخرون
منشور في: (2025-09-01)

A Limited Structural Modification Results in a Significantly More Efficacious Diazachrysene-Based Filovirus Inhibitor
حسب: Rekha G. Panchal, وآخرون
منشور في: (2012-08-01)

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates
حسب: John J. Suschak, وآخرون
منشور في: (2019-10-01)

Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies
حسب: Md Niaz Rahim, وآخرون
منشور في: (2019-03-01)

Correlates of Immunity to Filovirus Infection
حسب: Sina Bavari, وآخرون
منشور في: (2011-06-01)

Automation of Infectious Focus Assay for Determination of Filovirus Titers and Direct Comparison to Plaque and TCID<sub>50</sub> Assays
حسب: Patrick T. Keiser, وآخرون
منشور في: (2021-01-01)

MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS OF FILOVIRUSES: IMMUNOCHEMICAL PROPERTIES AND EVALUATION OF THEIR EFFICIENCY FOR IMMUNE DIAGNOSTICS OF MARBURG AND EBOLA VIRUSES
حسب: E. I. Kazachinskaia, وآخرون
منشور في: (2014-07-01)

New reverse sum Revan indices for physicochemical and pharmacokinetic properties of anti-filovirus drugs
حسب: W. Tamilarasi, وآخرون
منشور في: (2024-12-01)

Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats
حسب: Anitha D. Jayaprakash, وآخرون
منشور في: (2023-01-01)

Low-Input, High-Resolution 5′ Terminal Filovirus RNA Sequencing with ViBE-Seq
حسب: Stephen J. Ross, وآخرون
منشور في: (2024-07-01)

Sudan Virus Persistence in Immune-Privileged Organs of Nonhuman Primate Survivors
حسب: Brittany B. Beavis, وآخرون
منشور في: (2025-02-01)

Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
حسب: Ermela Paparisto, وآخرون
منشور في: (2021-09-01)

Individual and household risk factors for Ebola disease among household contacts in Mubende and Kassanda districts, Uganda, 2022
حسب: Stella M. Migamba, وآخرون
منشور في: (2024-05-01)

Algal Lectin Griffithsin Inhibits Ebola Virus Infection
حسب: Leah Liu Wang, وآخرون
منشور في: (2025-02-01)

Serological evidence of virus infection in Eidolon helvum fruit bats: implications for bushmeat consumption in Nigeria
حسب: Diego Cantoni, وآخرون
منشور في: (2023-11-01)

Comparison of Aerosol Stability of Different Variants of Ebola Virus and Marburg Virus and Virulence of Aerosolised Ebola Virus in an Immune-Deficient Mouse
حسب: Sophie J. Smither, وآخرون
منشور في: (2022-04-01)

Development of a Well-Characterized Rhesus Macaque Model of Ebola Virus Disease for Support of Product Development
حسب: Kendra J. Alfson, وآخرون
منشور في: (2021-02-01)

Marburg virus disease Mayhem: A new threat emerges in Rwanda
حسب: Pawan Kumar, وآخرون
منشور في: (2024-12-01)

Mutation of Hydrophobic Residues in the C-Terminal Domain of the Marburg Virus Matrix Protein VP40 Disrupts Trafficking to the Plasma Membrane
حسب: Kaveesha J. Wijesinghe, وآخرون
منشور في: (2020-04-01)

A Call to Action to Enhance Filovirus Disease Outbreak Preparedness and Response
حسب: Paul Roddy
منشور في: (2014-09-01)

Marburg Virus Disease: A Narrative Review
حسب: Arash Letafati, وآخرون
منشور في: (2025-05-01)

Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA)
حسب: Lindsay A. Parish, وآخرون
منشور في: (2023-06-01)

A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda
حسب: Luke Nyakarahuka, وآخرون
منشور في: (2020-07-01)

Animal models for Ebola and Marburg virus infections
حسب: Eri eNakayama, وآخرون
منشور في: (2013-09-01)

Development of a Well-Characterized Cynomolgus Macaque Model of Sudan Virus Disease for Support of Product Development
حسب: Kendra J. Alfson, وآخرون
منشور في: (2022-10-01)